Method and Device for Direct Production of Radio-Isotope Based Cancer Treatment Pharmaceuticals

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Source:
    Targeted News Service (USA), September 17, 2024, 1pp
  • Additional Information
    • Abstract:
      ALEXANDRIA, Virginia, Sept. 17 -- WESTINGHOUSE ELECTRIC COMPANY LLC, Cranberry Township, Pennsylvania has been assigned a patent (No. US 12090215 B2, initially filed Feb. 4, 2022) developed by three inventors Michael D. Heibel, Broomfield, Colorado; James Boyle, Aspinwall, Pennsylvania; and Kris Paserba, Butler, Pennsylvania, for "Method and device for direct production of radio-isotope based cancer treatment pharmaceuticals." The present disclosure is generally related to methods, systems and devices for direct production of a radioisotope-based cancer treatment pharmaceutical directly from a corresponding non-radioactive drug molecule precursor by irradiating the non-radioactive drug molecule precursor using neutrons produced by an electronic neutron generator...